Výsledky vyhledávání

[Multikinase inhibitors as a new approach in neovascular age-related macular degeneration (AMD) treatment: in vitro safety evaluations of axitinib, pazopanib and sorafenib for intraocular use]

Autor: S, Thiele, R G, Liegl, S, König, J, Siedlecki, J, Langer, K, Eibl, C, Haritoglou, A, Kampik, M, Kernt

Publikováno v: Klinische Monatsblatter fur Augenheilkunde. 230(3)

Multikinase inhibitors (MKI) interfere effectively at different levels of the neovascularisation cascade. Early clinical and experimental data suggest that MKIs represent a promising novel approach for the treatment of neovascular age-related macular

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::63c82fe4097b70974d447dcc29a3b6f1
https://pubmed.ncbi.nlm.nih.gov/23508753

Zobrazit plný text záznamu

[Improvement of fixation in diabetic macular oedema patients under intravitreal ranibizumab treatment]

Autor: F, Seidensticker, L, Reznicek, S, Cserhati, R G, Liegl, J, Langer, A, Wolf, A, Kampik, M, Ulbig, C, Haritoglou, M, Kernt

Publikováno v: Klinische Monatsblatter fur Augenheilkunde. 230(5)

The aim of this study was to evaluate the fixation and other functional and morphological alterations in patients with diabetic macular oedema (DMO) under intravitreal ranibizumab therapy.Thirty patients (39 eyes) with DMO with central involvement we

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::92dd5d87d1a6e13505b1ad985067cb33
https://pubmed.ncbi.nlm.nih.gov/23229224

Zobrazit plný text záznamu

[Navigated focal retinal laser therapy using the NAVILAS® system for diabetic macula edema]

Autor: M, Kernt, R, Cheuteu, R G, Liegl, F, Seidensticker, S, Cserhati, C, Hirneiss, C, Haritoglou, A, Kampik, M, Ulbig, A S, Neubauer

Publikováno v: Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft. 109(7)

The aim of this study was to investigate the accuracy of a navigated laser photocoagulator in clinically significant macular edema (CSME).Focal laser treatment for diabetic macular edema (DME) in 36 patients was digitally planned on fundus images and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::47b2346adf053ac6d1f32ec62e6dd7e7
https://pubmed.ncbi.nlm.nih.gov/22532038

Zobrazit plný text záznamu

[Intracameral moxifloxacin: a safe option for endophthalmitis prophylaxis? In vitro safety profile for intraocular application]

Autor: M, Kernt, C, Hirneiss, A S, Neubauer, R G, Liegl, K H, Eibl, A, Wolf, H, de Kaspar, M W, Ulbig, A, Kampik

Publikováno v: Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft. 107(8)

Moxifloxacin (Vigamox), a 4th-generation fluoroquinolone, covers most isolates causing endophthalmitis. It is safe and effective for systemic and topical use; however, only very limited data are available on prophylactic intracameral administration t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::25c0b315636e9ad463b69f56f78497a4
https://pubmed.ncbi.nlm.nih.gov/19756636

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání